A Clinical Study to Assess the Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Volunteers.

Trial Profile

A Clinical Study to Assess the Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Volunteers.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2012

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Adimmune Corporation
  • Most Recent Events

    • 01 Mar 2012 6-month follow-up results published in Clinical and Vaccine Immunology.
    • 19 Jan 2012 Last checked against ClinicalTrials.gov record (Parent trial: NCT01003145).
    • 19 Jan 2012 Last checked against ClinicalTrials.gov record (Parent trial: NCT01003145).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top